- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/4375 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring hetero atom, e.g. quinolizines, naphthyridines, berberine, vincamine
Patent holdings for IPC class A61K 31/4375
Total number of patents in this class: 3860
10-year publication summary
|
186
|
245
|
231
|
225
|
242
|
251
|
275
|
342
|
304
|
67
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Deciphera Pharmaceuticals, LLC | 238 |
71 |
| Novartis AG | 10450 |
56 |
| Incyte Corporation | 1047 |
52 |
| F. Hoffmann-La Roche AG | 7861 |
45 |
| Immunomedics, Inc. | 252 |
44 |
| Merck Sharp & Dohme LLC | 3726 |
43 |
| Bristol-myers Squibb Company | 4824 |
40 |
| Merck Patent GmbH | 5733 |
37 |
| Bayer Pharma AG | 1032 |
36 |
| Boehringer Ingelheim International GmbH | 4569 |
35 |
| Hoffmann-La Roche Inc. | 3652 |
34 |
| Bayer AG | 3437 |
30 |
| Gilead Sciences, Inc. | 2167 |
29 |
| Shenzhen HighTide Biopharmaceutical, Ltd. | 60 |
27 |
| Pfizer Inc. | 3394 |
26 |
| Takeda Pharmaceutical Company Limited | 2728 |
26 |
| Pliant Therapeutics, Inc. | 67 |
25 |
| Neurocrine Biosciences, Inc. | 448 |
24 |
| Genentech, Inc. | 4063 |
23 |
| Janssen Pharmaceutica N.V. | 3267 |
23 |
| Other owners | 3134 |